Figure 1. Syringe With 0.3 mL Luxturna (Lux 01)
Luxturna Kit
Product Images NDC 71394-415
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Luxturna (NDC 71394-415). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Spark Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2a. First Position Of The Operators During Preparation Of Luxturna Syringes (Lux 02)
Figure 2b. Second Position Of The Operators During Preparation Of Luxturna Syringes (Lux 03)
Figure 4. Volume Of Luxturna For Injection (Lux 05)
Figure 5a. Subretinal Injection Cannula Introduced Via Pars Plana (Lux 06)
Figure 5b. Tip Of The Subretinal Injection Cannula Placed Within The Recommended Site Of Injection (surgeon’s Point Of View) (Lux 07)
Figure 6. Mlmt Score Using Both Eyes At Baseline And One Year For Individual Subjects (Lux 08)
Figure 7. Mlmt Time-course Over Two Years: Using Both Eyes (Lux 09)
Principal Display Panel (Luxturna Diluent Label)
Not available.*
Principal Display Panel (Luxturna Label)
Principal Display Panel (Luxturna Carton Label)
Principal Display Panel (Luxturna Pouch Label)
The text provides information about a medication called voretigene neparvovec-rzyl, also known as LUXTURNA. This medication comes in single-dose vials and is administered by subcutaneous injection for the treatment of vision loss. The text also provides storage instructions and manufacturing information, including a lot number and expiration date.*
Principal Display Panel (Luxturna Pouch Label)
This is a description of a pharmaceutical product called LUXTURNA. The package includes a single-dose of vordigana nepanyovec-rz, which is administered by subcutaneous injection. The product is manufactured by Spark Therapeutics and has a storage requirement of 65 °C. There are additional details on the packaging, including a serial number and an expiry date. Full prescribing information and dosage instructions can be found in the package insert.*
Figure 3. Injection Apparatus Assembly (Lux04)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
